Jan Detmers

Jan Detmers is a highly accomplished professional in the field of biotechnology and scientific research. He currently holds the position of VP Multi-Omics (Cell Signaling & Metabolic Phenotyping) at Doppelganger Biosystem GmbH.12

Background and Expertise

Jan Detmers has a strong academic background in Molecular Microbiology and Genetics, having earned a Ph.D. from the prestigious Max Planck Institute. This educational foundation has equipped him with the necessary knowledge and skills for his current role in the biotech industry.

Professional Experience

Throughout his career, Jan Detmers has demonstrated leadership and expertise in various aspects of biotechnology:

Mentorship:: He has mentored a team of researchers who were preparing to launch their first start-up company in the field of sepsis diagnostics. This start-up was based on groundbreaking new technology.1

Research and Drug Development:: Detmers has been involved in research and drug development, as evidenced by his LinkedIn posts using hashtags such as #research and #drugdevelopment.2

Business Development:: Prior to his current role, Jan Detmers held the position of VP Business Development at Chimera Biotec GmbH.3

Current Role

As VP Multi-Omics at Doppelganger Biosystem GmbH, Jan Detmers likely focuses on integrating multiple types of biological data, such as genomics, proteomics, and metabolomics, to gain comprehensive insights into cellular processes and disease mechanisms. His expertise in cell signaling and metabolic phenotyping suggests a deep involvement in cutting-edge research and development within the biotechnology sector.